Neutrophils in Human Diseases

New England Journal of Medicine

Volumn 317, Issue 11, 1987, Pages 687-694

  Malech, Harry L ^a   Gallin, John I ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; HUMAN; INFLAMMATORY DISEASE; NEUTROPHIL; REVIEW;

CYTOPLASMIC GRANULES; GRANULOMATOUS DISEASE, CHRONIC; HUMAN; INFLAMMATION; MACROPHAGE-1 ANTIGEN; NEUTROPHILS; OXIDATION-REDUCTION; PEROXIDASE; RECEPTORS, COMPLEMENT;

EID: 0023269405     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198709103171107     Document Type: Review

References (126)

1. Quie PG. Neutrophil dysfunction and recurrent infection. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms. Vol. 1. Phagocytic cells. New York: Raven Press, 1982:163–85.
2. Buescher ES, Gallin JI. Disorders of phagocyte function. In: Fauci AS, Lichtenstein LM, eds. Current therapy in allergy and immunology, 1983–1984. Philadelphia: B.C. Decker, 1983:287–93.
3. White CJ, Gallin JI. Phagocyte defects. Clin Immunol Immunopathol 1986; 40: 50–61.
4. Boxer GJ, Curnutte JT, Boxer LA. Disorders of polymorphonuclear leukocyte function. II. Hosp Pract [Off] 1985; 20:(4): 129–38.
5. Rotrosen D, Gallin JI. Disorders of phagocyte function. Annu Rev Immunol 1987; 5: 127–50.
6. Dale DC, Guerry D IV, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine (Baltimore) 1979; 58: 128–44.
7. Gallin JI. The compromised host. In: Wyngaarden JB, Smith LH Jr, eds. Cecil textbook of medicine. 17th ed. Vol. 2. Philadelphia: W.B. Saunders, 1985:1477–85.
8. Van Dyke TE, Levine MJ, Genco RJ. Neutrophil function and oral disease. J Oral Pathol 1985; 14: 95–120.
9. Charon JA, Mergenhagen SE, Gallin JI. Gingivitis and oral ulceration in patients with neutrophil dysfunction. J Oral Pathol 1985; 14: 150–5.
10. Springer TA, Thompson WS, Miller J, Schmalstieg FC, Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984; 160: 1901–18.
11. Mantovani B. Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes. J Immunol 1975; 115: 15–7.
12. Goldstein IM, Kaplan HB, Radin A, Frosch M. Independent effects of IgG and complement upon human polymorphonuclear leukoctye function. J Immunol 1976; 117: 1282–7.
13. Arnaout MA, Todd RF III, Dana N, Melamed J. Schlossman SF, Cohen HR. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest 1983; 72: 171–9.
14. Kohl S, Springer TA, Schmalstieg FC, Loo LS. Anderson DC. Defective natural killer cytotoxicity and polymorphonuclear leukocyte antibody-dependent cellular cytotoxicity in patients with LFA-1/OKM-1 deficiency. J Immunol 1984; 133: 2972–8.
15. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611–6.
16. Anderson DC, Miller LJ, Schmalstieg FC, Rothlein R, Springer TA. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol 1986; 137: 15–27.
17. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987; 38: 175–94.
18. Crowley CA, Curnutte JT, Rosin RE, et al. An inherited abnormality of neutrophil adhesion: its genetic transmission and its association with a missing protein. N Engl J Med 1980; 302: 1163–8.
19. Anderson DC. Schmalstieg FC, Arnaout MA, et al. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest 1984; 74: 536–51.
20. Anderson DC, Schmalstieg FC, Finegold MJ, et al. The severe and moderate phenotypes of heritable Mac-1. LFA-1 deficiency: their qualitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152: 668–89.
21. Buescher ES, Gaither T, Nath J, Gallin JI. Abnormal adherence-related functions of neutrophils, monocytes, and Epstein–Barr virus-transformed B cells in a patient with C3bi receptor deficiency. Blood 1985; 65: 1382–90.
22. Ho M-K, Springer TA. Biosynthesis and assembly of the α and β subunits of Mac-1, a macrophage glycoprotein associated with complement receptor function. J Biol Chem 1983; 258: 2766–9.
23. Springer TA, Anderson DC. The importance of the Mac-1, LFA-1 glycoprotein family in monocyte and granulocyte adherence, chemotaxis and migration into inflammatory sites: insights from an experiment of nature. In: Evered D, Nugent J, O'Connor M, eds. Biochemistry of macrophages (Ciba Symposium 118). London: Pitman, 1986:102–26.
24. Harlan JM, Killen PD. Senecal FM, et al. The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood 1985; 66: 167–78.
25. Miedema F, Tetteroo PAT, Terpstra FG, et al. Immunologic studies with LFA-1-and Mol-deficient lymphocytes from a patient with recurrent bacterial infections. J Immunol 1985; 134: 3075–81.
26. Boxer LA, Hedley-Whyte ET, Stossel TP. Neutrophil actin dysfunction and abnormal neutrophil behavior. N Engl J Med 1974; 291: 1093–9.
27. Southwick FS, Holbook T, Howard T, et al. Neutrophil actin dysfunction is associated with a deficiency of Mol. Clin Res 1986; 34: 533A. abstract.
28. Seligmann B, Gallin JI. Neutrophils from a CR3 (C3bi) receptor deficient patient exhibit low ED-50 values for fmet-leu-phe stimulated responses and do not exhibit affinity adaption. Clin Res 1986; 34: 679A. abstract.
29. Nauseef WM, De Alarcon P, Bale JF, Clark RA. Aberrant activation and regulation of the oxidative burst in neutrophils with Mol glycoprotein deficiency. J Immunol 1986; 137: 636–42.
30. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980; 93: 480–9.
31. Klebanoff SJ. Oxygen-dependent cytotoxic mechanisms of phagocytes. In: Gallin JI. Fauci AS, eds. Advances in host defense mechanisms. Vol. 1. Phagocytic cells. New York: Raven Press, 1982:111–62.
32. Babior BM. The respiratory burst of phagocytes. J Clin Invest 1984; 73: 599–601.
33. Gallin JI. Fauci AS, eds. Advances in host defense mechanisms. Vol. 3. Chronic granulomatous disease. New York: Raven Press, 1983.
34. Gallin JI, Buescher ES, Seligmann BE, Nath J, Gaither TE, Katz P. Recent advances in chronic granulomatous disease. Ann Intern Med 1983; 99: 657–74.
35. Tauber AI, Borregaard N, Simons E, Wright J. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine (Baltimore) 1983; 62: 286–309.
36. Volkman DJ, Buescher ES, Gallin JI, Fauci AS. B Cell lines as models for inherited phagocytic diseases: abnormal Superoxide generation in chronic granulomatous disease and giant granules in Chediak–Higashi syndrome. J Immunol 1984; 133: 3006–9.
37. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory manual of neutrophil function. New York: Raven Press, 1986:100–3.
38. Gallin JI. Buescher ES. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation 1983; 7: 227–32.
39. Chin TW, Stiehm ER. Falloon J, Gallin JI. Corticosteroids in the treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 1987; 111: 349–52.
40. Clark RA, Klebanoff SJ. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 1979; 64: 913–20.
41. Henderson WR, Klebanoff SJ. Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils. J Biol Chem 1983; 258: 13522–7.
42. Clark RA, Borregaard N. Neutrophils autoinactivate secretory products by myeloperoxidase-catalyzed oxidation. Blood 1985; 65: 375–81.
43. Regelmann W, Hays N, Quie PG. Chronic granulomatous disease: historical perspective and clinical experience at the University of Minnesota Hospitals. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms. Vol. 3. Chronic granulomatous disease. New York: Raven Press, 1983:3–23.
44. Mills EL, Quie PG. Inheritance of chronic granulomatous disease. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms. Vol. 3. Chronic granulomatous disease. New York: Raven Press, 1983:25–53.
45. Weening RS. Adriaansz LH, Weemaes CMR, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr 1985; 107: 102–4.
46. Segal AW, Cross AR, Garcia RC, et al. Absence of cytochrome b-245 in chronic granulomatous disease: a multicenter European evaluation of its incidence and relevance. N Engl J Med 1983; 308: 245–51.
47. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for an inherited human disorder — chronic granulomatous disease — on the basis of its chromosomal location. Nature 1986; 322: 32–8.
48. Dinauer M, Orkin SH, Brown R, Jesaitis AJ, Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987; 327: 717–20.
49. Harper AM, Chaplin MF. Segal AW. Cytochrome b-245 from human neutrophils is a glycoprotein. Biochem J 1985; 227: 783–8.
50. Teahan C, Rowe P, Parker P, Totty N, Segal AW. The X-linked chronic granulomatous disease gene codes for the β-chain of cytochrome b245. Nature 1987; 327: 720–1.
51. Segal AW, Heyworth PG, Cockcroft S, Barrowman MM. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein. Nature 1985; 316: 547–9.
52. Caldwell SE, McCall CE, Hendricks CL, Leone PA, Bass DA, McPhail LC. Cell-free phosphorylation of a 48 KD protein and activation of NADPH oxidase is defective in neutrophils from a patient with chronic granulomatous disease: restoration with normal cytosol. Clin Res 1987; 35: 655A. abstract.
53. Hamers MN, de Boer M, Meerhof LJ, Weening RS, Roos D. Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease. Nature 1984; 307: 553–5.
54. Borregaard N, Cross AR, Herlin T, Jones OTG, Segal AW, Valerius NH. A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b. Eur J Clin Invest 1983; 13: 243–7.
55. Weening RS, Corbeel L, de Boer M, et al. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease: a third form of chronic granulomatous disease recognized by monocyte hybridization. J Clin Invest 1985; 75: 915–20.
56. Ohno Y, Buescher ES, Roberts R, Metcalf JA, Gallin JI. Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency. Blood 1986; 67: 1132–8.
57. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow: origin and content of azurophil and specific granules. J Exp Med 1971; 134: 907–34.
58. Wright DG. The neutrophil as a secretory organ of host defense. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms. Vol. 1. Phagocytic cells. New York: Raven Press, 1982:75–110.
59. Gallin JI. Neutrophil specific granules: a fuse that ignites the inflammatory response. Clin Res 1984; 32: 320–8.
60. Falloon J, Gallin JI. Neutrophil granules in health and disease. J Allergy Clin Immunol 1986; 77: 653–62.
61. Ganz T, Selsted ME. Szklarek D, et al. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427–35.
62. Weiss J, Victor M, Elsbach P. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest 1983; 71: 540–9.
63. O'Shea JJ, Brown EJ, Seligmann BE, Metcalf JA, Frank MM, Gallin JI. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol 1985; 134: 2580–7.
64. Fletcher MP, Gallin JI. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine. Blood 1983; 62: 792–9.
65. Gardner JP, Melnick DA, Malech HL. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate. J Immunol 1986; 136: 1400–5.
66. Yoon PS, Boxer LA, Mayo LA, Yang AY, Wicha MS. Human neutrophil laminin receptors: activation-dependent receptor expression. J Immunol 1987; 138: 259–65.
67. Borregaard N, Tauber AI. Subcellular localization of the human neutrophil NADPH oxidase: b-cytochrome and associated flavoprotein. J Biol Chem 1984; 259: 47–52.
68. Ohno Y, Seligmann BE, Gallin JI. Cytochrome b translocation to human neutrophil plasma membranes and Superoxide release. J Biol Chem 1985; 260: 2409–14.
69. Dewald B, Bretz LJ, Baggiolini M. Release of gelatinase from a novel secretory compartment of human neutrophils. J Clin Invest 1982; 70: 518–25.
70. Petrequin PR, Todd RF III. Devall LJ, Boxer LA, Cumutte JT III. Association between gelatinase release and increased plasma membrane expression of the Mol glycoprotein. Blood 1987; 69: 605–10.
71. Gallin JI. Neutrophil specific granule deficiency. Annu Rev Med 1985; 36: 263–74.
72. Ambruso DR, Johnston RB Jr. Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest 1981; 67: 352–60.
73. Broxmcyer HE, DeSousa M. Smithyman A, et al. Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood 1980; 55: 324–33.
74. Ganz T, Metcalf JA, Gallin JI, Lehrer RI. Two genetic disorders that affect human neutrophils are associated with deficiencies of microbicidal and cytotoxic granule proteins. Clin Res 1987; 35: 424A. abstract.
75. Gallin JI, Fletcher MP, Seligmann BE. Hoffstein S, Cehrs K, Mounessa N. Human neutrophil-specific granule deficiency: a model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood 1982; 59: 1317–29.
76. Parmley RT, Tzeng DY, Baehner RL, Boxer LA. Abnormal distribution of complex carbohydrates in neutrophils of a patient with lactoferrin deficiency. Blood 1983; 62: 538–48.
77. Davis JM, Dineen P, Gallin JI. Neutrophil dcgranulation and abnormal chemotaxis after thermal injury. J Immunol 1980; 124: 1467–71.
78. Wolach B, Coates TD, Hugh TE, Baehner RL, Boxer LA. Plasma lactoferrin reflects granulocyte activation via complement in burn patients. J Lab Clin Med 1984; 103: 284–93.
79. Ambruso DR, Bentwood B, Henson PM, Johnston RB Jr. Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res 1984; 18: 1148–53.
80. Gallin JI, Metcalf JA, Roos D, Seligmann B, Friedman MM. Organelle-depleted human neutrophil cytoplasts used to study fmet-leu-phe receptor modulation and cell function. J Immunol 1984; 133: 415–21.
81. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 1981; 95: 293–301.
82. Nauseef WM, Root RK, Malech HL. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 1983; 71: 1297–307.
83. Lehrer RI, Cline MJ. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 1969; 48: 1478–88.
84. Cech P, Stalder HS, Widmann J-J, Rohner A, Miescher PA. Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med 1979; 66: 149–53.
85. Nauseef WM, Metcalf JA, Root RK. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood 1983; 61: 483–92.
86. Johnson KR, Nauseef WM, Care A, et al. Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res 1987; 15: 2013–28.
87. Nauseef WM. Genetic basis for hereditary myeloperoxidase deficiency. Clin Res 1987; 35: 484A. abstract.
88. Weil SC, Rosner GL, Reid MS, et al. cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase in RNA upon induction of HL-60 cells. Proc Natl Acad Sci USA 1987; 84: 2057–61.
89. Malawista SE. Gouty inflammation. Arthritis Rheum 1977; 20: S241–S248.
90. Weissmann G, Korchak H. Rheumatoid arthritis: the role of neutrophil activation. Inflammation 1984; 8: Suppl: S3–S14.
91. Spilberg I, Mehta J. Binding characteristics of radioiodinated crystal-induced chemotactic factor to human neutrophils. J Lab Clin Med 1984; 104: 939–46.
92. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 1978; 89: 660–76.
93. Wolff K. Winkelmann RK, eds. Vasculitis. Philadelphia: W.B. Saunders, 1980.
94. Holdsworth SR, Bellomo R. Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit. Kidney lnt 1984; 26: 162–9.
95. Lawley TJ, Bielory L, Gascon P. Yancey KB, Young NS, Frank MM. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med 1984; 311: 1407–13.
96. Ragaz A, Ackerman AB. Evolution, maturation, and regression of lesions of psoriasis: new observations and correlation of clinical and histologic findings. Am J Dermatopathol 1979; 1: 199–214.
97. Glínski W, Mansbridge J. Polymorphonuclear leukocytes in psoriasis. Cutis 1985; 35: 441–2.
98. Cooper PH, Frierson HF, Greer KE. Subcutaneous neutrophilic infiltrates in acute febrile neutrophilic dermatosis. Arch Dermatol 1983; 119: 610–1.
99. Jorizzo JL, Hudson RD, Schmalstieg FC, et al. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 1984; 10: 205–14.
100. Hickman JG. Pyoderma gangrenosum. Clin Dermatol 1983; 1: 102–13.
101. Chester JF, Ross JS, Malt RA, Weitzman SA. Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol 1985; 121: 284–90.
102. Wandall JH. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol 1985; 20: 1151–6.
103. Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: a possible initiator of an extra myocardial mechanism of ischemic injury. Circ Res 1985; 57: 119–30.
104. Rowe GT, Eaton LR, Hess ML. Neutrophil-derived. oxygen-free radical-mediated cardiovascular dysfunction. J Mol Cell Cardiol 1984; 16: 1075–9.
105. Bednar M, Smith B, Pinto A, Mullane KM. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 1985; 57: 131–41.
106. Allan G, Bhattacherjee P, Brook CD, Read NG, Parke AJ. Myeloperoxi-dase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct — the effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation. J Cardiovasc Pharmacol 1985; 7: 1154–60.
107. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982; 155: 264–75.
108. Stevens JH, Raffin TA. Adult respiratory distress syndrome. I. Aetiology and mechanisms. Postgrad Med J 1984; 60: 505–13.
109. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Annu Rev Respir Dis 1986; 133: 218–25.
110. Janoff A. Biochemical links between cigarette smoking and emphysema. J Appl Physiol 1983; 55: 285–93.
111. Murphy KR, Marsh WR, Glezen LS, Irvin CG, Wilson MC, Larsen GL. Inflammation and the late phase reaction in asthma: the effect of polymorphonuclear leukocyte depletion on airways obstruction and bronchial hyperreactivity in an animal model. Bull Eur Physiopathol Respir 1986; 22: Suppl 7: 48–53.
112. Stevens JH, O'Hanley P. Shapiro JM, et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 1986; 77: 1812–6.
113. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–4.
114. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 8667–71.
115. Ognibene FP, Martin SE, Parker MM, et al. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315: 547–51.
116. Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36: 207–16.
117. Lamanske RF Jr, Guthman DA, Kaliner M. The biologic activity of mast cell granules. VII. The effect of anti-neutrophil antibody-induced neutropenia on rat cutaneous late phase reactions. J Immunol 1983; 131: 929–33.
118. White MV, Kaliner MA. Baer H. Simulated neutrophils release a histamine releasing factor. J Allergy Clin Immunol 1986; 77: 132. abstract.
119. Till GO, Hatherill JR, Tourtellotte WW, Lutz MJ, Ward PA. Lipid peroxidation and acute lung injury after thermal trauma to skin: evidence of a role for hydroxyl radical. Am J Pathol 1985; 119: 376–84.
120. Ambruso DR, Johnston RB Jr. Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest 1981; 67: 352–60.
121. Umeda T, Hara T, Hayashida M, Niijima T. Role of hydroxyl radical in neutrophil-mediated cytotoxicity. Cell Mol Biol 1985; 31: 229–33.
122. Fox RB. Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest 1984; 74: 1456–64.
123. Hatherill JR, Till GO, Bruner LH, Ward PA. Thermal injury, intravascular hemolysis, and toxic oxygen products. J Clin Invest 1986; 78: 629–36.
124. Weitzman SA, Weitburg AB, Clark EP, Stossel TP. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985; 227: 1231–3.
125. Trush MA, Seed JL, Kensler TW. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc Natl Acad Sci USA 1985; 82: 5194–8.
126. Smedly LA, Tonnesen MG, Sandhaus RA, et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77: 1233–43.